Literature DB >> 33784203

Determining the Prognosis of Bell's Palsy Based on Severity at Presentation and Electroneuronography.

Derek A Escalante1, Ronit E Malka2, Allison G Wilson3, Zachary S Nygren1, Kristofer A Radcliffe4, Douglas S Ruhl1, Aurora G Vincent5, Marc H Hohman1.   

Abstract

OBJECTIVE: To examine the demographics of Bell's palsy and determine how House-Brackmann (HB) grade at nadir and electroneuronography (ENoG) results correlate with HB grade after recovery and development of synkinesis. STUDY
DESIGN: Retrospective cohort study.
SETTING: Tertiary care military medical center.
METHODS: Patients with acute Bell's palsy and adequate follow-up, defined as 6 months or return to HB grade I function, were included. Demographic information, HB scores at nadir and recovery, and ENoG results were collected.
RESULTS: A total of 112 patient records were analyzed. Ages ranged from 8 to 87 years with peaks at 21 to 25 and 61 to 65 years. Among patients, 16.3% reached a nadir at HB II, 41.9% at HB III, 5.4% at HB IV, 16.3% at HB V, and 20.1% at HB VI. The overall recovery rate was 73.2% to HB I function, 17.0% to HB II, and 9.8% to HB III. The chance of recovery to HB I decreased as the severity of paralysis increased (rs = -1.0, P < .0001). Mean time to recovery to HB I was 6 weeks. Greater degeneration on ENoG suggested worse recovery (rs = 0.62, P = .01). Patients with HB V and VI were most likely to develop synkinesis.
CONCLUSION: More severe paralysis increased the chance of recovery to HB II or III function. The granularity of this study provides prognostic insights that may inform the counseling of patients with Bell's palsy with respect to prognosis and recovery timeline.

Entities:  

Keywords:  Bell’s palsy; ENoG; electrodiagnostic testing; facial weakness; synkinesis

Mesh:

Year:  2021        PMID: 33784203     DOI: 10.1177/01945998211004169

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Delayed Recovery in Idiopathic Sudden Sensorineural Hearing Loss.

Authors:  Gina Na; Ki-Won Kim; Keun-Woo Jung; Jimin Yun; Taek-Yoon Cheong; Jeon-Mi Lee
Journal:  J Clin Med       Date:  2022-05-16       Impact factor: 4.964

Review 2.  Review of Drug Therapy for Peripheral Facial Nerve Regeneration That Can Be Used in Actual Clinical Practice.

Authors:  Soo Young Choi; Jung Min Kim; Junyang Jung; Dong Choon Park; Myung Chul Yoo; Sung Soo Kim; Sang Hoon Kim; Seung Geun Yeo
Journal:  Biomedicines       Date:  2022-07-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.